Search results
Results From The WOW.Com Content Network
Pfizer and BioNTech set their price at $120, and Moderna doses will be $129. Novavax shots will be $130 per dose. The vaccine is recommended for everyone six months and older.
The Food and Drug Administration on Tuesday authorized a second booster of Pfizer-BioNTech and Moderna for adults 50 years and older, announcing that a fourth shot improves protection against ...
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.
Moderna, Pfizer/BioNTech and relative newcomer to the COVID vaccine market Novavax have created versions of their shots aimed at the XBB.1.5 subvariant, the dominant variant through most of 2023.
"It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation and chief innovation officer for UC San Francisco, said at a campus town hall last week.
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week ...
October 12, 2022 at 10:24 AM. The CDC approved Pfizer/BioNTech's ( PFE / BNTX) bivalent COVID-19 booster for children ages 5-11 and Moderna's ( MRNA) bivalent booster for ages 6-17 Wednesday ...
(Reuters) -The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the ...